中、美军队战伤感染防治用药比较  

Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force

作　　者：邵尉[1,2] 舒丽芯[1] 李捷玮[1] 

机构地区：[1]第二军医大学药学院,上海200433 [2]沈阳军区沈阳药材仓库,辽宁沈阳110026

出　　处：《药学实践杂志》2014年第1期71-73,共3页Journal of Pharmaceutical Practice

摘　　要：目的比较中、美军队战伤感染防治用药的差别,吸取有价值的信息和经验。方法对中、美两军战伤感染的防治用药指南进行比较,分析两者差异。结果两军在战伤感染防治用药方面略有不同,主要表现在阶梯救治用药和不同伤部用药上。结论美军战伤感染用药指南在感染防治的临床路径和给药细则方面可供借鉴。Objective To compare the differences in the drug utilization for infection prevention in combat injuries between the PLA and USA armed force. Methods The guidelines for the prevention of infections associated with combat-related injuries and tactical medical emergency protocols of USA armed force were compared with the combat injury treatment regulation of PLA. Results There are some differences between the prevention and medicine use of war injure infection of Chinese and American Armed Force, es- pecially in variety selection and principle of drug selection in different echelon. Conclusion The references could be taken from the principle of drug utilization of prevention and treatment in combat injuries from USA Armed Force.

关 键 词：战伤 感染 防治 用药 比较 

分 类 号：R978[医药卫生—药品]